It has been shown that miR‐485‐5p overexpression decreased breast tumour development and promoted chemosensitivity partly via modulating survivin expression.35 Previous study indicated that miR‐485‐5p expression was down‐regulated in the serum of NSCLC cells and patients. This evidence concerns the gene BIRC5 and breast neoplasm.